AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ECO ANIMAL HEALTH GROUP PLC

Director's Dealing Nov 30, 2022

7612_dirs_2022-11-30_86ed8337-2197-4174-8708-95953faabcfa.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1248I

Eco Animal Health Group PLC

30 November 2022

ECO Animal Health Group plc

(''ECO" or the "Company") (AIM: EAH)

Director/PDMR Dealings

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has been notified that on 29 November 2022, David Hallas, Chief Executive Officer, purchased 20,394 ordinary shares of 5 pence each ("Ordinary Shares") at a price of 98.0 pence per Ordinary Share.

Following this transaction, David Hallas' total interest in the Company is 53,394 Ordinary Shares, representing approximately 0.08 per cent. of the Company's total issued share capital.

Details of the transactions can be found in the Notification of Dealing Form below.

For further information, please contact:

ECO Animal Health Group plc

David Hallas (CEO)

Christopher Wilks (CFO)
020 8447 8899
IFC Advisory

Graham Herring

Zach Cohen
020 3934 6630
Singer Capital Markets (Nominated Adviser & Joint Broker)

Mark Taylor

George Tzimas
020 7496 3000
Investec (Joint Broker)

Gary Clarence

Alex Penney

Carlo Spingardi
020 7597 5970
Equity Developments

Hannah Crowe

Matt Evans
020 7065 2692

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name David Hallas
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name ECO Animal Health Group plc
b) LEI 2138009XN9DJ3YP70B55
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 5 pence each
Identification code GB0032036807
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
98.0 pence 20,394
d) Aggregated information N/A - Single transaction
- Aggregated volume
- Price
e) Date of the transaction 29 November 2022
f) Place of the transaction London Stock Exchange, AIMX

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBSBDBIUXDGDG

Talk to a Data Expert

Have a question? We'll get back to you promptly.